Ategrity Specialty president buys 1,000 shares

Ategrity Specialty Insurance Co Holdings (ASIC) President and Chief Underwriting Officer Chris Schenk purchased 1,000 shares of common stock on October 26, 2026, at $24.29 per share.

Rhea-AI Filing Summary

Ategrity Specialty Insurance Co Holdings (ASIC) President and Chief Underwriting Officer Chris Schenk purchased 1,000 shares of common stock on October 26, 2026, at $24.29 per share. His directly held position after the purchase was 3,500 shares. No Rule 10b5-1 plan was reported for the purchase.

Insider Trade Summary

Net Buyer: 1,000 shares

Net Buy 1 txn

Insider Schenk Chris

Role See Remarks

Bought 1,000 shs ($24K)

Type	Security	Shares	Price	Value
Purchase	Common Stock	1,000	$24.29	$24K

Holdings After Transaction: Common Stock — 3,500 shares (Direct)

Key Figures

Shares purchased: 1,000 shares Purchase price: $24.29 per share Direct shares held after purchase: 3,500 shares

3 metrics

Shares purchased 1,000 shares October 26, 2026

Purchase price $24.29 per share October 26, 2026

Direct shares held after purchase 3,500 shares Following the October 26, 2026 purchase

Key Terms

non-derivative, Rule 10b5-1 plan, open market or private transaction

3 terms

non-derivative financial

"the common-stock purchase was reported as a non-derivative transaction"

Rule 10b5-1 plan regulatory

"no Rule 10b5-1 plan was reported for the purchase"

A Rule 10b5-1 plan is a prearranged, written schedule that lets corporate insiders buy or sell company stock at set times or amounts, even if they later learn material nonpublic information. Think of it like setting an automatic thermostat for trades: it creates a clear record that trades were planned in advance, reducing the risk of insider-trading accusations and helping investors trust that insider transactions are routine rather than based on secret information.

open market or private transaction financial

"purchase described as in the open market or a private transaction"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many ASIC shares did Chris Schenk buy, and at what price?

Chris Schenk purchased 1,000 shares of Ategrity Specialty Insurance Co Holdings common stock on October 26, 2026, at $24.29 per share. His directly held position after the purchase was 3,500 shares, and no Rule 10b5-1 plan was reported.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/27/2026 - 09:24 AM EDT Accepted by SEC EDGAR 10/27/2026 - 09:24 AM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Schenk Chris

(Last) (First) (Middle)

9 WEST 57TH STREET

33RD FLOOR

(Street)

NEW YORK NEW YORK 10019

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Ategrity Specialty Insurance Co Holdings [ ASIC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	See Remarks

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
10/26/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	10/26/2026		P		1,000	A	$24.29	3,500	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

President and Chief Underwriting Officer.

	/s/ Eric Crespolini, Attorney-in-Fact	10/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)